Schroder Investment Management Group
KITE

Schroder Investment Management Group’s Kite Pharma, Inc. KITE Stock Holding History

Schroder Investment Management Group’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-8,444
Closed -$472K – 1214
2016
Q3 		$472K Sell
8,444
-16,011
-65% -$892K ﹤0.01% 979
2016
Q2 		$1.22M Hold
24,455
– – ﹤0.01% 880
2016
Q1 		$1.08M Buy
24,455
+12,593
+106% +$610K ﹤0.01% 906
2015
Q4 		$731K Buy
+11,862
New +$835K ﹤0.01% 945

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Schroder Investment Management Group's KITE Position: Q4 2016 in Review

Schroder Investment Management Group sold out of Kite Pharma, Inc. (KITE) in Q4 2016, closing a stake of 8,444 shares — an estimated $472K sold.

Schroder Investment Management Group first reported a position in KITE in Q4 2015 and held it in 4 quarters. The position peaked at $1.22M in Q2 2016. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

  • Schroder Investment Management Group reported no remaining Kite Pharma, Inc. position as of Q4 2016 after selling out during the quarter.
  • Schroder Investment Management Group sold 8,444 Kite Pharma, Inc. shares in Q4 2016, an estimated $472K.
  • Schroder Investment Management Group first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 4 quarters.
  • Schroder Investment Management Group's Kite Pharma, Inc. position peaked at $1.22M in Q2 2016.
  • 184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on Schroder Investment Management Group's 13F filing for Q4 2016, filed 10 Feb 2017.